5Raz I, Mouritzen U, Vaz J, et al. Addition of biphasic insulin as- part 30 to rosiglitazone in type 2 diabetes mellitus that is poorly con- trolled with glibenclamide monotherapy [ J ]. Clin Ther, 2003,25 (12) :3109-3123.
6Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, mefformin, or insulin in patients with type 2 diabetes mellitus : progressive requird for multiple therapies ( UKPDS 49 ). UK Prospective Diabetes Study(UKPDS) Group[ J]. JAMA, 1999, 281 (21) :2005-2011.
7Albu J, Raja-Khan N. The management of the obese diabetic patient [J]. Prim Care, 2003,30(2) :465-491.
8中华医学会糖尿病学分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2010:70.
9Parulkar A A, Pendergrass M L, Granda-Ayala R, et al.Nonhy- poglycemic effects of thiazolidinediones[J].Ann Intern Med, 2001, 134(1): 61-67.
10Albu J,Raja-Khan N.The management of the obesediabetic patient[J].Prim Care,2003,30(2):465.
